Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorus cholinesterase inhibitors
Patent 6114347 Issued on September 5, 2000. Estimated Expiration Date: 
August 23, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
August 23, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3760805 3760806 3764984 3845770 3916899 Osmotically driven fluid dispenser Sustained action dosage forms Patent #: 4137300 InventorsAssigneeApplicationNo. 656207 filed on 08/23/1996US Classes:514/297, Acridines (including hydrogenated)514/304, Tropanes (including nor or dehydro form)514/346, Chalcogen and acyclic nitrogen bonded directly to the same carbon514/411, Tricyclo ring system having the five-membered hetero ring as one of the cyclos514/479, With an additional active ingredient514/823ANTIDOTEExaminersPrimary: Jordan, KimberlyAttorney, Agent or FirmForeign Patent References
International ClassesA61K 031/44A61K 031/40 A61K 031/27 Foreign Application Priority Data1993-12-10 DEAbstractA pharmaceutical formulation for the prophylaxis and preliminary treatment of a poisoning caused by organophosphorus cholinesterase inhibitors is characterized in that it consists of an active substance combination of at least one parasympathomimetic and at least one parasympatholytic.Other References
| |
